Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Rating) announced its quarterly earnings results on Tuesday. The company reported ($0.92) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.71) by ($0.21), Briefing.com reports. The company had revenue of $11.50 million for the quarter, compared to the consensus estimate of $12.12 million. Rhythm Pharmaceuticals had […]
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Rating) CAO William T. Roberts sold 912 shares of the stock in a transaction that occurred on Wednesday, March 29th. The stock was sold at an average price of $17.50, for a total value of $15,960.00. Following the completion of the sale, the chief accounting officer now directly owns […]
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Rating) dropped 4.4% on Friday . The company traded as low as $16.19 and last traded at $16.44. Approximately 78,900 shares changed hands during trading, a decline of 87% from the average daily volume of 612,098 shares. The stock had previously closed at $17.20. Wall Street Analysts Forecast Growth […]
CARE-BBS multi-country survey of 242 caregivers of individuals with Bardet-Biedl syndrome (BBS) provides extensive details on impact of hyperphagia and.